Pictet Asset Management’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-11,211
Closed -$39.2K 2057
2024
Q3
$39.2K Buy
+11,211
New +$39.2K ﹤0.01% 2009